| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.082 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |